MedTrace Logo

An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer

NCT01266564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 205

Last updated 2017-08-11

No results posted yet for this study

Summary

This observational study will assess the progression-free survival, overall response and safety of Avastin (bevacizumab) in combination with chemotherapy in a real life setting in patients with metastatic colorectal cancer. Data will be collected from patients for approximately 2 years.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-03
Primary Completion
2015-07-10
Completion
2015-07-10

Countries

  • Lebanon

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01266564 on ClinicalTrials.gov